Table 4 Correlation between the expression of EPCAM and prognosis
Low expression of EPCAM | High expression of EPCAM | χ2 | P | |
|---|---|---|---|---|
Intestinal-type | 6.9.7% | 34.2% | 29.15 | 0.001 |
Diffuse-type | 12.9% | 8.6% | 37.11 | 0.001 |
PN0 | 78.2% | 40.7% | 35.77 | 0.001 |
PN1 | 33.1% | 15.0% | 37.72 | 0.001 |
PN2 | 19.0% | 8.6% | 17.31 | 0.001 |
PN3 | 4.3% | 0% | 3.21 | 0.073 |
Stage I | 89.1% | 62.5% | 4.89 | 0.027 |
Stage II | 60.3% | 47.4% | 7.648 | 0.006 |
Stage III | 22.2% | 12.9% | 35.58 | 0.0001 |
Stage IV | 0% | 2.3% | 0.268 | 0.605 |